Contents

Search


CD101; immunoglobulin superfamily member 2; Glu-Trp-Ile EWI motif-containing protein 101; EWI-101; cell surface glycoprotein V7 (CD101, EWI101, IGSF2, V7)

Function: 1) role as inhibitor of T-cells proliferation induced by CD3 2) inhibits expression of IL2RA on activated T-cells & secretion of IL2 3) inhibits tyrosine kinases required for IL2 production & cellular proliferation 4) inhibits phospholipase C-gamma-1/PLCG1 phosphorylation & subsequent CD3-induced changes in intracellular free Ca+2 5) prevents nuclear translocation of NFAT to nucleus 6) role in inhibition of T-cell proliferation via IL10 secretion by cutaneous dendritic cells Structure: - N-Glycosylated - contains 7 Ig-like C2-type domains (immunoglobulin-like) Compartment: membrane Expression: - expressed in lung, thymus, small intestine - expressed in cutaneous dendritic cells, activated T-cells, monocytes, granulocytes, epithelial cells with dendritic morphology Pathology: - expressed in some leukemic cells, CD4(+) CD56(+) blastic tumor cells from patients with Langerhans cell histiocytosis - marker of CD4(+) CD56(+) leukemic tumor cells (putative)

General

cluster-of-differentiation antigen; cluster designation antigen; CD antigen glycoprotein immunoglobulin superfamily protein

Properties

SIZE: entity length = 1021 aa MW = 115 kD COMPARTMENT: cellular membrane MOTIF: signal sequence {1-20} immunoglobulin superfamily domain {22-139} MOTIF: cysteine residue {C43} MODIFICATION: cysteine residue {C121} N-glycosylation site {N44} cysteine residue {C121} MODIFICATION: cysteine residue {C43} immunoglobulin superfamily domain {144-265} MOTIF: cysteine residue {C168} MODIFICATION: cysteine residue {C249} cysteine residue {C249} MODIFICATION: cysteine residue {C168} EWI {253-255} immunoglobulin superfamily domain {279-389} MOTIF: cysteine residue {C304} MODIFICATION: cysteine residue {C377} N-glycosylation site {N322} cysteine residue {C377} MODIFICATION: cysteine residue {C304} immunoglobulin superfamily domain {408-525} MOTIF: cysteine residue {C434} MODIFICATION: cysteine residue {C511} cysteine residue {C511} MODIFICATION: cysteine residue {C434} immunoglobulin superfamily domain {541-651} MOTIF: cysteine residue {C562} MODIFICATION: cysteine residue {C640} cysteine residue {C640} MODIFICATION: cysteine residue {C562} immunoglobulin superfamily domain {656-794} MOTIF: cysteine residue {C697} MODIFICATION: cysteine residue {C778} cysteine residue {C778} MODIFICATION: cysteine residue {C697} immunoglobulin superfamily domain {808-925} MOTIF: cysteine residue {C834} MODIFICATION: cysteine residue {C909} cysteine residue {C909} MODIFICATION: cysteine residue {C834} transmembrane domain {955-975}

Database Correlations

OMIM 604516 UniProt Q93033 PFAM correlations Entrez Gene 9398 Kegg hsa:9398

References

  1. http://www.pathologyoutlines.com/cd100247.html 21 June 2005
  2. Protein Reviews on the Web http://mpr.nci.nih.gov/prow/guide/1116508525_g.htm
  3. UniProt :accession Q93033